NUV-422

N/A

Report date: 2022/08/02 14:05:28
NME

Base Information

Drug NameNUV-422
Drug Alias NameNUV-422
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 2 inhibitorsCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 6 inhibitors
TargetsCyclin-dependent kinase 2Cyclin-dependent kinase 4Cyclin-dependent kinase 6
Therapy Area/IndicationsMetastatic breast cancerProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNuvation Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNuvation Bio Inc
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A